Clinical pharmacological innovation in the treatment of depression
- 3 April 2023
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Clinical Pharmacology
- Vol. 16 (4) , 349-362
Abstract
Deficiencies in standard of care antidepressants are driving novel drug discovery. A new age of antidepressant medications has emerged with the introduction of rapid-acting antidepressants with eff... Novel antidepressants have been introduced for patient use: (S)-ketamine, brexanolone, dextromethorphan/bupropion.Newly emerging antidepressants are currently in clinical development including (R)-...Keywords
This publication has 126 references indexed in Scilit:
- Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?Expert Opinion on Pharmacotherapy, 2011
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studiesJournal of Psychopharmacology, 2010
- Taming the Ketamine TigerAnesthesiology, 2010
- Glutamate-based antidepressants: 20 years onTrends in Pharmacological Sciences, 2009
- Augmentation of antidepressants with atypical antipsychotics for treatment‐resistant major depressive disorderActa Psychiatrica Scandinavica, 2008
- Antidepressant Efficacy of the Antimuscarinic Drug ScopolamineArchives of General Psychiatry, 2006
- Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in DepressionNeuropsychopharmacology, 2003
- Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)European Neuropsychopharmacology, 1997
- Functional antagonists at the NMDA receptor complex exhibit antidepressant actionsEuropean Journal of Pharmacology, 1990
- Psychic distress and the immune responseLife Sciences, 1985